| UniProt ID | SYEM_HUMAN | |
|---|---|---|
| UniProt AC | Q5JPH6 | |
| Protein Name | Probable glutamate--tRNA ligase, mitochondrial | |
| Gene Name | EARS2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 523 | |
| Subcellular Localization | Mitochondrion matrix. | |
| Protein Description | Catalyzes the attachment of glutamate to tRNA(Glu) in a two-step reaction: glutamate is first activated by ATP to form Glu-AMP and then transferred to the acceptor end of tRNA(Glu).. | |
| Protein Sequence | MAALLRRLLQRERPSAASGRPVGRREANLGTDAGVAVRVRFAPSPTGFLHLGGLRTALYNYIFAKKYQGSFILRLEDTDQTRVVPGAAENIEDMLEWAGIPPDESPRRGGPAGPYQQSQRLELYAQATEALLKTGAAYPCFCSPQRLELLKKEALRNHQTPRYDNRCRNMSQEQVAQKLAKDPKPAIRFRLEQVVPAFQDLVYGWNRHEVASVEGDPVIMKSDGFPTYHLACVVDDHHMGISHVLRGSEWLVSTAKHLLLYQALGWQPPHFAHLPLLLNRDGSKLSKRQGDVFLEHFAADGFLPDSLLDIITNCGSGFAENQMGRTLPELITQFNLTQVTCHSALLDLEKLPEFNRLHLQRLVSNESQRRQLVGKLQVLVEEAFGCQLQNRDVLNPVYVERILLLRQGHICRLQDLVSPVYSYLWTRPAVGRAQLDAISEKVDVIAKRVLGLLERSSMSLTQDMLNGELKKLSEGLEGTKYSNVMKLLRMALSGQQQGPPVAEMMLALGPKEVRERIQKVVSS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 44 | Phosphorylation | VRVRFAPSPTGFLHL EEEEECCCCCCCEEC | 31.50 | 20068231 | |
| 46 | Phosphorylation | VRFAPSPTGFLHLGG EEECCCCCCCEECCH | 44.92 | 20068231 | |
| 56 | Phosphorylation | LHLGGLRTALYNYIF EECCHHHHHHHHHHH | 26.51 | 18452278 | |
| 59 | Phosphorylation | GGLRTALYNYIFAKK CHHHHHHHHHHHCHH | 11.94 | 18452278 | |
| 61 | Phosphorylation | LRTALYNYIFAKKYQ HHHHHHHHHHCHHCC | 5.48 | 18452278 | |
| 67 | Phosphorylation | NYIFAKKYQGSFILR HHHHCHHCCCEEEEE | 19.87 | 22210691 | |
| 91 | Ubiquitination | VPGAAENIEDMLEWA CCCHHHCHHHHHHHC | 3.41 | 24816145 | |
| 108 | Methylation | PPDESPRRGGPAGPY CCCCCCCCCCCCCCC | 58.78 | - | |
| 134 | Phosphorylation | ATEALLKTGAAYPCF HHHHHHHCCCCCCCC | 31.83 | 26074081 | |
| 138 | Phosphorylation | LLKTGAAYPCFCSPQ HHHCCCCCCCCCCHH | 10.45 | 26074081 | |
| 143 | Phosphorylation | AAYPCFCSPQRLELL CCCCCCCCHHHHHHH | 12.10 | 25159151 | |
| 160 | Ubiquitination | EALRNHQTPRYDNRC HHHHCCCCCCCCHHH | 11.37 | 24816145 | |
| 178 | Ubiquitination | SQEQVAQKLAKDPKP CHHHHHHHHHCCCCH | 40.45 | 29967540 | |
| 178 | Acetylation | SQEQVAQKLAKDPKP CHHHHHHHHHCCCCH | 40.45 | 25953088 | |
| 184 | Ubiquitination | QKLAKDPKPAIRFRL HHHHCCCCHHHHHHH | 58.16 | 24816145 | |
| 256 | Succinylation | EWLVSTAKHLLLYQA HHHHHHHHHHHHHHH | 34.57 | - | |
| 256 | Succinylation | EWLVSTAKHLLLYQA HHHHHHHHHHHHHHH | 34.57 | - | |
| 326 | Phosphorylation | AENQMGRTLPELITQ HHCCHHCCHHHHHHH | 40.72 | 24043423 | |
| 332 | Phosphorylation | RTLPELITQFNLTQV CCHHHHHHHCCCCCC | 39.47 | 24043423 | |
| 337 | Phosphorylation | LITQFNLTQVTCHSA HHHHCCCCCCCCCHH | 23.30 | 24043423 | |
| 340 | Phosphorylation | QFNLTQVTCHSALLD HCCCCCCCCCHHHHC | 8.49 | 24043423 | |
| 343 | Phosphorylation | LTQVTCHSALLDLEK CCCCCCCHHHHCHHH | 23.82 | 24043423 | |
| 387 | Ubiquitination | VEEAFGCQLQNRDVL HHHHHCCCCCCCCCC | 46.60 | 21890473 | |
| 393 | Ubiquitination | CQLQNRDVLNPVYVE CCCCCCCCCCHHHHH | 5.13 | 23503661 | |
| 398 | Phosphorylation | RDVLNPVYVERILLL CCCCCHHHHHHHHHH | 9.61 | - | |
| 447 | 2-Hydroxyisobutyrylation | EKVDVIAKRVLGLLE HHHHHHHHHHHHHHH | 31.73 | - | |
| 447 | Acetylation | EKVDVIAKRVLGLLE HHHHHHHHHHHHHHH | 31.73 | 25953088 | |
| 456 | Ubiquitination | VLGLLERSSMSLTQD HHHHHHHHCCCHHHH | 22.48 | 21890473 | |
| 462 | Ubiquitination | RSSMSLTQDMLNGEL HHCCCHHHHHHHHHH | 39.13 | 23503661 | |
| 470 | Ubiquitination | DMLNGELKKLSEGLE HHHHHHHHHHHHCCC | 47.57 | - | |
| 470 | Acetylation | DMLNGELKKLSEGLE HHHHHHHHHHHHCCC | 47.57 | 19809829 | |
| 473 | Phosphorylation | NGELKKLSEGLEGTK HHHHHHHHHCCCCCH | 38.20 | 22985185 | |
| 480 | Ubiquitination | SEGLEGTKYSNVMKL HHCCCCCHHHHHHHH | 58.50 | 21890473 | |
| 480 | Malonylation | SEGLEGTKYSNVMKL HHCCCCCHHHHHHHH | 58.50 | 26320211 | |
| 486 | Malonylation | TKYSNVMKLLRMALS CHHHHHHHHHHHHHC | 39.84 | 26320211 | |
| 486 | Ubiquitination | TKYSNVMKLLRMALS CHHHHHHHHHHHHHC | 39.84 | 23503661 | |
| 486 | Acetylation | TKYSNVMKLLRMALS CHHHHHHHHHHHHHC | 39.84 | 19608861 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SYEM_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SYEM_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SYEM_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of SYEM_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 614924 | Combined oxidative phosphorylation deficiency 12 (COXPD12) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-486, AND MASS SPECTROMETRY. | |